🚀 VC round data is live in beta, check it out!
Diamond Biofund Valuation Multiples
Discover revenue and EBITDA valuation multiples for Diamond Biofund and similar public comparables like Fondul Proprietatea, Ascencio, Kinea Hedge Fund, Invalda INVL and more.
Diamond Biofund Overview
About Diamond Biofund
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
Founded
2013
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$273M
Diamond Biofund Stock Performance
Diamond Biofund has current market cap of $394M, and enterprise value of $273M.
Market Cap Evolution
Diamond Biofund's stock price is $0.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $273M | $394M | 0.5% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDiamond Biofund Valuation Multiples
Diamond Biofund Financial Valuation Multiples
As of April 20, 2026, Diamond Biofund has market cap of $394M and EV of $273M.
Equity research analysts estimate Diamond Biofund's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $394M | XXX | $394M | XXX | XXX | XXX |
| EV (current) | $273M | XXX | $273M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Diamond Biofund Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Diamond Biofund Margins & Growth Rates
Diamond Biofund's revenue in the last fiscal year grew by —.
Diamond Biofund Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | (52%) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Diamond Biofund Public Comps
See public comps and valuation multiples for other Asset Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Diamond Biofund | XXX | XXX | XXX | XXX | XXX | XXX |
| Fondul Proprietatea | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascencio | XXX | XXX | XXX | XXX | XXX | XXX |
| Kinea Hedge Fund | XXX | XXX | XXX | XXX | XXX | XXX |
| Invalda INVL | XXX | XXX | XXX | XXX | XXX | XXX |
| Future Generation Investment Company | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Diamond Biofund M&A Activity
Diamond Biofund acquired XXX companies to date.
Last acquisition by Diamond Biofund was on XXXXXXXX, XXXXX. Diamond Biofund acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Diamond Biofund
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDiamond Biofund Investment Activity
Diamond Biofund invested in XXX companies to date.
Diamond Biofund made its latest investment on XXXXXXXX, XXXXX. Diamond Biofund invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Diamond Biofund
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Diamond Biofund
| When was Diamond Biofund founded? | Diamond Biofund was founded in 2013. |
| Where is Diamond Biofund headquartered? | Diamond Biofund is headquartered in Taiwan. |
| Is Diamond Biofund publicly listed? | Yes, Diamond Biofund is a public company listed on Taiwan Stock Exchange. |
| What is the stock symbol of Diamond Biofund? | Diamond Biofund trades under 6901 ticker. |
| When did Diamond Biofund go public? | Diamond Biofund went public in 2022. |
| Who are competitors of Diamond Biofund? | Diamond Biofund main competitors are Fondul Proprietatea, Ascencio, Kinea Hedge Fund, Invalda INVL. |
| What is the current market cap of Diamond Biofund? | Diamond Biofund's current market cap is $394M. |
| Is Diamond Biofund profitable? | No, Diamond Biofund is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.